| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.38 | 5e-13 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.33 | 1e-09 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.2 | 8e-05 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.2 | 0.0002 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.17 | 0.002 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.17 | 0.003 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | 0.14 | 0.009 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.14 | 0.01 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.14 | 0.03 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.12 | 0.04 |